Protease Inhibitors Toxicity
Mostrando 1-12 de 24 artigos, teses e dissertações.
-
1. CaracterizaÃÃo BioquÃmica Parcial do LÃtex de Cryptostegia grandiflora R. Br. e AÃÃo Contra o Vetor da Dengue. / Biochemical characterization of latex of Cryptostegia grandiflora and larvicidal activity against Aedes aegypti
Cryptostegia grandiflora R. Br. is a shurb belonging to Apocynaceae family popularly known as âunha de bruxaâ. There are few studies available about the latex from this species and preliminary assays had shown its action against Dengue vector. Thus, this study aimed to characterize the biochemical properties of Cr. grandiflora latex and to evaluate the act
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 25/02/2010
-
2. Proteases de Leishmania: novos alvos para o desenvolvimento racional de fármacos
Leishmania causes tegumental and visceral diseases called leishmaniasis. Disease control is possible interrupting the transmission cycle, but HIV co-infection, chemotheraphy toxicity and lack of a vaccine are paramount difficulties. So, is necessary to study new Leishmania molecules and investigate the possibility to develop rational drugs using these molecu
Química Nova. Publicado em: 2010
-
3. Novas propriedades do SKTI (Inibidor de tripsina de soja): inibição para elastase neutrofílica humana e efeitos no processo de injúria pulmonar aguda
Seeds from legumes including the Glycine max are known to be a rich source of protease inhibitors. The soybean Kunitz trypsin inhibitor (SKTI) has been well characterised and has been found to exhibit many biological activities. However its effects on inflammatory diseases have not been studied to date. In this study, SKTI was purified from a commercial soy
Publicado em: 2010
-
4. Análise proteômica em urina e rim de ratos submetidos a tratamento crônico com flúor / Proteomic analysis of urine kidney in fluoride-treated rat
Two-dimensional gel electrophoresis (2D-PAGE) based proteomics approach was used to better understand the molecular mechanisms of renal injury induced by fluoride (F) and define potentials biomarkers of fluorosis. Three groups of weanling male Wistar rats (21 days old) were treated with drinking water containing 0 (control), 5, or 50 ppm F for 60 days (n=6/g
Publicado em: 2008
-
5. Alterations in renal function in HIV/AIDS patients treated with therapeutic regimens including indinavir / "Alterações na função renal em pacientes HIV/AIDS tratados com esquemas terapêuticos incluindo indinavir"
Complicações renais e urológicas incluindo nefrolitíase, cristalúria, cólica renal e lombalgia, são eventos adversos bem conhecidos do indinavir (IDV), um inibidor de protease (IP) largamente utilizado no tratamento de pacientes infectados com o vírus da imunodeficiência humana (HIV). Prévios estudos em ratos demonstraram que o IDV, um potente IP c
Publicado em: 2004
-
6. Caracterização farmacologica do relaxamento de corpo cavernoso de coelho induzido pelo veneno de Tityus serrulatus
Títyus serrufatus ís the most dangerous scorpíon of the subfamily Tityinae in Brazíl because of the high toxicity of its venom and its widespread distribution in populous urban centers of southeastern region of the country. The most important clinical manifestations of the human envenomation by Títyus serrulatus are intense local pain and an immediate l
Publicado em: 1997
-
7. Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes
Human rhinoviruses, the most important etiologic agents of the common cold, are messenger-active single-stranded monocistronic RNA viruses that have evolved a highly complex cascade of proteolytic processing events to control viral gene expression and replication. Most maturation cleavages within the precursor polyprotein are mediated by rhinovirus 3C p
The National Academy of Sciences.
-
8. In Vitro Antiviral Interaction of Lopinavir with Other Protease Inhibitors
The in vitro inhibition of wild-type human immunodeficiency virus (HIV) by combinations of lopinavir and six other protease inhibitors over a range of two-drug combination ratios was evaluated. Combinations of lopinavir with indinavir, nelfinavir, amprenavir, tipranavir, and BMS-232632 generally displayed an additive relationship. In contrast, a consistent,
American Society for Microbiology.
-
9. In vitro inhibition of human immunodeficiency virus (HIV) type 1 replication by C2 symmetry-based HIV protease inhibitors as single agents or in combinations.
C2 symmetry-based human immunodeficiency virus (HIV) protease inhibitors were examined in vitro as single agents or in combination with 3'-azido-2',3'-dideoxythymidine (AZT) or 2',3'-dideoxyinosine for activity against HIV type 1 (HIV-1). Ten C2 symmetry-based or pseudo-C2 symmetry-based HIV protease inhibitors were active against a laboratory strain (HIV-1I
-
10. Human Immunodeficiency Virus Protease Inhibitors Serve as Substrates for Multidrug Transporter Proteins MDR1 and MRP1 but Retain Antiviral Efficacy in Cell Lines Expressing These Transporters
The human immunodeficiency virus type 1 (HIV-1) protease inhibitors (PIs)—saquinavir, ritonavir, nelfinavir, and indinavir—interact with the ABC-type multidrug transporter proteins MDR1 and MRP1 in CEM T-lymphocytic cell lines. Calcein fluorescence was significantly enhanced in MDR1+ CEM/VBL100 and MRP1+ CEM/VM-1-5 cells incubated in the presence of vari
American Society for Microbiology.
-
11. Cell-Based Fluorescence Assay for Human Immunodeficiency Virus Type 1 Protease Activity
The human immunodeficiency virus type 1 (HIV-1) protease is essential for production of infectious virus and is therefore a major target for the development of drugs against AIDS. Cellular proteins are also cleaved by the protease, which explains its cytotoxic activity and the consequent failure to establish convenient cell-based protease assays. We have exp
American Society for Microbiology.
-
12. Preclinical evaluation of antiviral activity and toxicity of Abbott A77003, an inhibitor of the human immunodeficiency virus type 1 protease.
A synthetic, symmetry-based inhibitor of the human immunodeficiency virus type 1 (HIV-1) protease, A77003, was evaluated for antiviral activity and cytotoxicity in vitro in human peripheral blood lymphocytes or cell lines H9, CEM, and U937. Toxicity and antiviral activity of the HIV-1 protease inhibitor were compared with those of the reverse transcriptase i